Structural heart devices are used in the treatment of abnormalities of the heart’s structures, and coronary artery diseases. These devices are used to perform heart valve repair and replacement procedures such as left atrial appendage (LAA) occlusion, heart failure interventional device therapies, and occlusion of ASDs, VSDs.
The rising incidents of cardiovascular diseases is the major factor that is expected to drive the global market for structural heart devices. Moreover, introduction of advanced technologies to monitor cardiac functions will also help to enhance the demand for cardiac surgeries that proportionally add novel opportunities for the global structural heart devices market in the forecast period.
Get FREE Sample Copy of this Report at http://www.theinsightpartners.com/sample/TIPHE100001164
The “Global Structural Heart Devices Market Analysis to 2025” is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global structural heart devices market with detailed market segmentation by product, procedure, end user, and geography. The global structural heart devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
On the basis of product the market is segmented into occluders, annuloplasty rings, heart valve balloons and others. Based on the procedure, the market is segmented into surgical aortic valve replacement, transcatheter aortic valve replacement, mitral repair and left atrial appendage closure. The structural heart devices market by end user is classified as hospitals, ambulatory centers and cardiac centers.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global structural heart devices based on product, procedure and end user. It also provides market size and forecast till 2025 for overall structural heart devices market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East & Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
Inquire About this Report at http://www.theinsightpartners.com/inquiry/TIPHE100001164
North America followed by Europe, is expected to dominate the structural heart devices market in the global arena due to the increasing prevalence of cardiovascular diseases such as aortic stenosis, mitral valve disease. Moreover, the introduction of enabling technologically advanced products such as the trifecta valve with glide technology also boost the growth of the market in the region. The Asia-Pacific region is anticipated to show a significant growth rate over the next five years in the global structural heart devices market due to the increasing number of cancer cases in the region.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key structural heart devices manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Abbott, Medtronic, Koninklijke Philips N.V., Boston Scientific Corporation, CryoLife, Inc., Edwards Lifesciences Corporation, LivaNova PLC, JenaValve Technology, Inc., Medical Technology Est., Micro Interventional Devices, Inc. and others.
Get Complete Report With TOC and Company Profiles at http://www.theinsightpartners.com/reports/structural-heart-devices-market
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.